Orphan Medicine Incentives: How to Address the Unmet Needs of Rare Disease Patients by Optimizing the European Orphan Medicinal Product Landscape Guiding Principles and Policy Proposals by the European Expert Group for Orphan Drug Incentives (OD Expert Group)

Today policy makers face the challenge to devise a policy framework that improves orphan medicinal product (OMP) development by creating incentives to deliver treatments where there are none and to authorize innovative and transformative treatments where treatments already exist. The European Expert...

Descripción completa

Detalles Bibliográficos
Autores principales: Aartsma-Rus, Annemieke, Dooms, Marc, Le Cam, Yann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717920/
https://www.ncbi.nlm.nih.gov/pubmed/34975469
http://dx.doi.org/10.3389/fphar.2021.744532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717920/
https://www.ncbi.nlm.nih.gov/pubmed/34975469
http://dx.doi.org/10.3389/fphar.2021.744532

Ejemplares similares